Home » Topics » Conferences

Conferences
RSS

rhIL-11 effective in rats with adjuvant arthritis

Nov. 19, 1997

No Comments

rhIL-10 evaluated for safety and efficacy in RA patients

Nov. 19, 1997

No Comments

New cardiotonic agent reported by Japanese academics

Nov. 19, 1997

No Comments

Merck & Co. isolates novel antifungal agent with potent, broad-spectrum activity

Nov. 18, 1997

No Comments

Second-generation, highly selective COX-2 inhibitors developed at Merck

Nov. 18, 1997

No Comments

SomatoKine shows potential for the treatment of osteoporosis

Nov. 18, 1997

No Comments

Safety, immunogenicity and efficacy of anti-TNF antibody in RA patients

Nov. 18, 1997

No Comments

Data presented on Shionogi's S-2150

Nov. 18, 1997

No Comments

COX-2 antisense therapy for rheumatoid arthritis

Nov. 18, 1997

No Comments

Improvement in early and established arthritis with antiangiogenic therapy

Nov. 18, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Conferences
RSS

rhIL-11 effective in rats with adjuvant arthritis

rhIL-10 evaluated for safety and efficacy in RA patients

New cardiotonic agent reported by Japanese academics

Merck & Co. isolates novel antifungal agent with potent, broad-spectrum activity

Second-generation, highly selective COX-2 inhibitors developed at Merck

SomatoKine shows potential for the treatment of osteoporosis

Safety, immunogenicity and efficacy of anti-TNF antibody in RA patients

Data presented on Shionogi's S-2150

COX-2 antisense therapy for rheumatoid arthritis

Improvement in early and established arthritis with antiangiogenic therapy

Today's news in brief

Today's news in brief

By the numbers: US leads charge of cell and gene therapies

Regulatory actions for Oct. 31, 2024

Nanocube’s nanorobots to revolutionize cancer diagnosis, treatment

Conferences RSS

Conferences
RSS